Capabilities
Active Pharmaceutical Ingredients
Product
Facilities
Finished Dose Formulations
Product
Facilities
Antimicrobial Solutions
Novel Medicine
Featured Portfolio
Antimicrobial Stewardship Program
Exblifep
Research
Fighting AMR
Fighting AMR
Antimicrobial Stewardships
Company
About us
Careers
Our thoughts
Investor
Contact
Contact
Stockexchanges
Intimation under Regulation 30 of SEBI (LODR)- Withdrawal of Credit rating
September 1, 2020
Outcome of Board meeting-September 07,2020
September 1, 2020
Disclosure under Regulation 30 of the SEBI (LODR )Regulations,2015- September 17, 2020
September 1, 2020
Intimation of Trading Window closure – September 30, 2020
September 1, 2020
Intimation Under Regulation 30 Of SEBI (LODR) Regulations,2015 – Credit Rating
September 1, 2020
Compliances-Certificate under Regulation 74 (5) of SEBI (DP) Regulations, 2018– September 30, 2020
September 1, 2020
Corporate Governance Report for the Quarter ended September 2020 under Regulation 27(2) of SEBI (LODR) 2015
September 1, 2020
Post Reduction Share Holding Pattern 2020
September 1, 2020
Shareholding pattern for the quarter ended September 30, 2020
September 1, 2020
Compliance Certificate under Regulation- 7(3) for the half year ended September 30,2020
September 1, 2020
Issue Of 14,300 Optionally Convertible Debentures as per Approved Resolution Plan
September 1, 2020
Trading approval from exchanges for the reduction and consolidation
September 1, 2020
Reconciliation report for the quarter ended September 30, 2020
September 1, 2020
Certificate Under Regulation 40(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations,2015
September 1, 2020
Newspaper Publication dated November 13, 2020 - Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2020
September 1, 2020
Intimation of Trading Window Closure
August 1, 2020
Previous
1
...
Next
24 / 36